veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
regkirona
celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immuun-sera en immunoglobulinen, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
ronapreve
roche registration gmbh - casirivimab, imdevimab - covid-19 virus infection - immuun-sera en immunoglobulinen, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. zie hoofdstuk 4. 4 en 5.
dexamethason cf 20 mg/ml, injectievloeistof
centrafarm b.v. van de reijtstraat 31-e 4814 ne breda - dexamethasondinatriumfosfaat 26,3 mg/ml samenstelling overeenkomend met ; dexamethason 20 mg/ml - oplossing voor injectie - benzylalcohol (e 1519) 10,5 mg/ml ; dinatriumedetaat 2-water ; glycerol (e 422) ; natriumhydroxide (e 524) ; natriummetabisulfiet (e 223) ; stikstof (head space) (e 941) ; trinatriumcitraat 2-water (e 331) ; water, gezuiverd, - dexamethasone
dexamethason cf 4 mg/ml, oplossing voor injectie
centrafarm b.v. van de reijtstraat 31-e 4814 ne breda - dexamethasondinatriumfosfaat 5,3 mg/ml samenstelling overeenkomend met ; dexamethason 4 mg/ml - oplossing voor injectie - benzylalcohol (e 1519) 10,5 mg/ml ; dinatriumedetaat 2-water ; glycerol (e 422) ; natriumhydroxide (e 524) ; natriummetabisulfiet (e 223) ; stikstof (head space) (e 941) ; trinatriumcitraat 2-water (e 331) ; water voor injectie, benzylalcohol (e 1519) 10,5 mg/ml ; dinatriumedetaat 2-water ; glycerol (e 422) ; natriumhydroxide (e 524) ; natriummetabisulfiet (e 223) ; stikstof (head space) (e 941) ; trinatriumcitraat 2-water (e 331) ; water, gezuiverd, - dexamethasone
oradexon 5 mg/ml, injectievloeistof
aspen pharma trading limited 3016 lake drive, citywest business campus dublin 24 (ierland) - dexamethasondinatriumfosfaat samenstelling overeenkomend met ; dexamethason - oplossing voor injectie - dinatriumedetaat 2-water ; fosforzuur (e 338) ; glycerol (e 422) ; natriumhydroxide (e 524) ; stikstof (head space) (e 941) ; water voor injectie, - dexamethasone
ethanol 70 % gedenatureerd conforma cut. opl.
conforma sa-nv - ethanol 75 g - oplossing voor cutaan gebruik - alcohol 0.7 ml/ml - ethanol
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
dexamethasonfosfaat hameln 4 mg/ml oplossing voor injectie
dexamethasondinatriumfosfaat 4,4 mg/ml samenstelling overeenkomend met ; dexamethasonfosfaat 4 mg/ml ; samenstelling overeenkomend met dexamethason 3,3 mg/ml - oplossing voor injectie - dinatriumedetaat 2-water ; natriumhydroxide (e 524) ; propyleenglycol (e 1520) ; stikstof (head space) (e 941) ; water voor injectie